High-dose cytosine arabinoside plus etoposide as initial treatment for acute myeloid leukaemia: a single centre study.

In a single centre, 52 newly diagnosed patients with acute myeloid leukemia (AML) under the age of 56 years received induction chemotherapy commencing with high-dose cytosine arabinoside (Ara-C) and etoposide (Protocol BF11), followed by Ara-C, 6 thioguanine (6TG). A total of 67% of patients entered...

Descripción completa

Detalles Bibliográficos
Autores principales: Parikh, P., Powles, R., Treleaven, J., Helenglass, G., Gore, M., Rose, M., Talbot, D., Milan, S., Smith, C., Pinkerton, R.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1990
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971542/
https://www.ncbi.nlm.nih.gov/pubmed/2245176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971542/
https://www.ncbi.nlm.nih.gov/pubmed/2245176

Ejemplares similares